ATYR

aTyr Pharma (ATYR)

About aTyr Pharma (ATYR)

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Details

Daily high

$0.75

Daily low

$0.72

Price at open

52 Week High

$7.29

52 Week Low

$0.64

Market cap

71.8M

Dividend yield

0.00%

Volume

Avg. volume

2.4M

P/E ratio

-.88

aTyr Pharma News